Aptorum Group Limited (APM)
Symbol Info
Listed Symbol APM
Name Aptorum Group Limited
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $383,450
Latest Fiscal EPS $-0.53
Price Info
21 Day Moving Average $16.1297
21 Day EMA $16.165130
50 Day Moving Average $16.2694
50 Day EMA $16.997880
200 Day EMA $17.857100
200 Day Moving Average 18.034420
52 Week High $33.28
52 Week Low $11.80
52 Week Change $
Alpha 0.174391
Beta -6.5548
Standard Deviation 0.418352
R2 0.420940
Periods 10
Share Information
10 Day Average Volume 1,255
20 Day Average Volume 2,550
30 Day Average Volume 2,723
50 Day Average Volume 3,372
Outstanding Shares 29,035,116
Float Shares 29,035,116
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 5
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months -
Institute Holdings Percent -
Institute Sold Previous 3 Months 1,237
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-0.1653996
7 Day Percent Change -1.04%
21 Day Price Change $-0.0965996
21 Day Percent Change -0.61%
30 Day Price Change $-1.0354004
30 Day Percent Change -6.14%
Month To Date Price Change $-0.6954
Month To Date Percent -4.21%
90 Day Price Change $-6.5854
90 Day Percent Change -29.40%
Quarter To Date $-0.6954
Quarter To Date Percent -4.21%
180 Day Price Change $2.414600
180 Day Percent Change 18.02%
200 Day Price Change $2.314600
200 Day Percent Change 17.15%
Year To Date $0.634600
Year To Date Percent 4.18%
Profile
Description Aptorum Group Ltd is a Hong Kong based pharmaceutical company currently in the preclinical stage, engaged in developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. The company is pursuing therapeutic and diagnostic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas. It also has projects focused on surgical robotics. The operating business segments are Therapeutics, and Non-Therapeutics segments. The company derives revenue from Healthcare service.
Details
Issue Type CS
Market Cap $459,178,745
Sec Type
Auditor Marcum Bernstein & Pinchuk LLP
Total Shares Outstanding 29,035,116
CEO Ian Huen
Employees 41
Last Audit UQ
Classification
CIK 0001734005
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 148 Connaught Road Central
17th Floor, Guangdong Investment Tower
Hong Kong,
Website https://www.aptorumgroup.com
Facisimile +852 28507286
Telephone +852 21176611
Email
Key Ratios
Profitability
EBIT Margin -2,290
EBITDA Margin -2,290
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -11.7
Profit Margin TOT -
Income Statements
Revenue $596,580
Revenue Per Share $0.0904
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $452,785,132
Price To Sales 174.887920
Price To Free Cash -65.5
PE High Last 5 Years -
Price To Book 18.4
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 18.4
Financial Strength
Total Debt To Equity 0.0
Int Coverage -
Current Ratio 13.0
Leverage Ratio 0.8
Quick Ratio 12.0
Long Term Debt To Capital -
Assets
Receivables Turnover 0.8
Invoice Turnover 35.40
Assets Turnover -
Management Effectiveness
Return Assets -55.68
Return On Equity -74.36
Return On Capital -56.17
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
最近閲覧した銘柄
NASDAQ
APM
Aptorum
今すぐ無料会員登録 し、ADVFNのストリーミングモニターで株価情報を見よう!

モニターには110もの銘柄を一度に表示することができ、またこれらは全て無料 でお使いいただけます。

LSEとPLUSのデータはリアルタイムで表示されています。 東証、福証、札証、NYSE及びAMEXのデータは実際の取引から最低20分遅れで表示されています。
その他のデータは特に時間表示されている場合以外は、実際の取引から15分遅れで表示されています。
P: V:jp D:20191021 16:16:38